StockNews.com cut shares of Simulations Plus (NASDAQ:SLP – Free Report) from a hold rating to a sell rating in a research report report published on Monday. Other equities research analysts have also ...
William Blair reissued their outperform rating on shares of Simulations Plus (NASDAQ:SLP – Free Report) in a research report sent to investors on Tuesday,RTT News reports. William Blair also issued ...
Simulations Plus is benefiting from the growing use of computational tools in drug discovery, which would be boosted by the FDA Modernization Act 2.0. The biosimulation market is highly fragmented and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results